Literature DB >> 11062711

Lymphatic microvessel density in epithelial ovarian cancer: its impact on prognosis.

P Birner1, M Schindl, A Obermair, C Plank, G Breitenecker, H Kowalski, G Oberhuber.   

Abstract

BACKGROUND: The influence of lymphatic microvessel density (MVD) on survival in epithelial ovarian cancer is still unknown, owing to the fact that until recently no reliable immunohistologic markers for lymphatic endothelium were available.
MATERIALS AND METHODS: By using a polyclonal antibody staining podoplanin, a novel marker for lymphatic endothelium, lymphatic MVD in tissue samples of 90 patients with epithelial ovarian cancer treated by radical surgery and chemotherapy was investigated. Survival analysis was performed using univariate and multivariate analysis. Furthermore, lymphatic MVD was compared to MVD assessed by CD34 immunostaining.
RESULTS: Lymphatic MVD was significantly lower than CD34 MVD (p < 0.0001). There was no significant association between lymphatic MVD and various histological and clinical parameters. Lymphatic MVD had no influence on overall survival and disease free survival (p = 0.4627 and p = 0.4337, respectively; log-rank test).
CONCLUSION: The formation of lymphatic vessels has no influence on the progression of epithelial ovarian cancer.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11062711

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  6 in total

1.  Importance of lymph vessels in gastric cancer: a prognostic indicator in general and a predictor for lymph node metastasis in early stage cancer.

Authors:  Y Nakamura; H Yasuoka; M Tsujimoto; K Kurozumi; M Nakahara; K Nakao; K Kakudo
Journal:  J Clin Pathol       Date:  2006-01       Impact factor: 3.411

2.  Expression of lymphangiogenic factors and evidence of intratumoral lymphangiogenesis in pancreatic endocrine tumors.

Authors:  Bence Sipos; Wolfram Klapper; Marie-Luise Kruse; Holger Kalthoff; Dontscho Kerjaschki; Günter Klöppel
Journal:  Am J Pathol       Date:  2004-10       Impact factor: 4.307

3.  Lymphangiogenesis induced by VEGF-C and VEGF-D promotes metastasis and a poor outcome in breast carcinoma: a retrospective study of 61 cases.

Authors:  Yan Gu; Xiaoliang Qi; Shanyu Guo
Journal:  Clin Exp Metastasis       Date:  2008-05-30       Impact factor: 5.150

4.  Role of lymphangiogenesis in epithelial ovarian cancer.

Authors:  S S Sundar; H Zhang; P Brown; S Manek; C Han; K Kaur; M F L Charnock; D Jackson; T S Ganesan
Journal:  Br J Cancer       Date:  2006-06-05       Impact factor: 7.640

5.  Vascular endothelial growth factor-D is an independent prognostic factor in epithelial ovarian carcinoma.

Authors:  Y Yokoyama; D S Charnock-Jones; D Licence; A Yanaihara; J M Hastings; C M Holland; M Emoto; M Umemoto; T Sakamoto; S Sato; H Mizunuma; S K Smith
Journal:  Br J Cancer       Date:  2003-01-27       Impact factor: 7.640

6.  CCL21/CCR7 interaction promotes cellular migration and invasion via modulation of the MEK/ERK1/2 signaling pathway and correlates with lymphatic metastatic spread and poor prognosis in urinary bladder cancer.

Authors:  Yang Xiong; Fang Huang; Xiaozhou Li; Zhi Chen; Deyun Feng; Haiying Jiang; Wei Chen; Xiangyang Zhang
Journal:  Int J Oncol       Date:  2017-05-17       Impact factor: 5.650

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.